Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increased consumer awareness and demand
3.2.1.2 Expansion of product offerings
3.2.1.3 Legalization and regulatory changes
3.2.2 Industry pitfalls & challenges
3.2.2.1 High production costs
3.2.2.2 Advertising and marketing restrictions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Cannabigerol (CBG)
5.3 Cannabinol (CBN)
5.4 Cannabichromene (CBC)
5.5 Tetrahydrocannabivarin (THCV)
5.6 Cannabigerolic acid (CBGA)
5.7 Other minor cannabinoids
Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Isolates
6.3 Distillate
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pain management
7.3 Neurological disorders
7.4 Anxiety/stress
7.5 Sleep disorders
7.6 Joint pain & inflammation
7.7 Skin care
7.8 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Cosmetic companies
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)
9.1 Key trends, by zone
9.2 Northeast
9.2.1 Connecticut
9.2.2 Maine
9.2.3 Massachusetts
9.2.4 New Hampshire
9.2.5 Rhode Island
9.2.6 Vermont
9.2.7 New Jersey
9.2.8 New York
9.2.9 Pennsylvania
9.3 East North Central
9.3.1 Wisconsin
9.3.2 Michigan
9.3.3 Illinois
9.3.4 Indiana
9.3.5 Ohio
9.4 West North Central
9.4.1 North Dakota
9.4.2 South Dakota
9.4.3 Nebraska
9.4.4 Kansas
9.4.5 Minnesota
9.4.6 Iowa
9.4.7 Missouri
9.5 South Atlantic
9.5.1 Delaware
9.5.2 Maryland
9.5.3 District of Columbia
9.5.4 Virginia
9.5.5 West Virginia
9.5.6 North Carolina
9.5.7 South Carolina
9.5.8 Georgia
9.5.9 Florida
9.6 East South Central
9.6.1 Kentucky
9.6.2 Tennessee
9.6.3 Mississippi
9.6.4 Alabama
9.7 West South Central
9.7.1 Oklahoma
9.7.2 Texas
9.7.3 Arkansas
9.7.4 Louisiana
9.8 Mountain States
9.8.1 Idaho
9.8.2 Montana
9.8.3 Wyoming
9.8.4 Nevada
9.8.5 Utah
9.8.6 Colorado
9.8.7 Arizona
9.8.8 New Mexico
9.9 Pacific Central
9.9.1 California
9.9.2 Alaska
9.9.3 Hawaii
9.9.4 Oregon
9.9.5 Washington
Chapter 10 Company Profiles
10.1 BayMedica (InMed Pharmaceuticals Inc.)
10.2 Fresh Bros Hemp Company
10.3 GVB Biopharma
10.4 GenCanna
10.5 KND Labs
10.6 Laurelcrest
10.7 Mile High Labs
10.8 Open Book Extracts
10.9 Rhizo Sciences
10.10 Verus Extracts
10.11 Viobin
10.12 ZERO POINT EXTRACTION, LLC
